Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin and Albendazole Combination for STH in Preschool Children
NCT07045493Phase 2Enrolling by invitation
- Sponsor
- icddr,b
- Start
- Jul 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CHILD-IVITAB in soil-transmitted helminthiasis (STH), sponsored by icddr,b. Started Jul 2025; status: enrolling by invitation.
02
Drugs
CHILD-IVITAB
03
Conditions
soil-transmitted helminthiasis (STH)
Beyond the preview
Go deeper on NCT07045493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07045493.